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VIRAL CONTRIBUTIONS TO CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE.
POSSIBLE MECHANISMS AND APPROACHES TO DETECTION
My interest in the problem of the role of viruses in chronic obstructive
respiratory disease (CORD) of man is as a virologist and epidemiologist
rather than as a specialist in CORD. Hence, my presentation will take the
form of speculations made in a state of at least partial ignorance of past and
current studies of CORD. My hope is that, uninhibited as I am by "knowl-
edge" as to what cannot be done, I may have some advantage over workers
now fully immersed in the problem. These speculations will be concerned
with two somewhat different problems.
The first has to do with mechanisms by which viruses might play a role.
Hopefully, identification of these may suggest approaches to development
of animal models. The second relates to means by which viral contributions
to human disease might be detected, some of which I am sure, are currently
being explored. An important question is whether additional efforts to col-
lect information and specimens relevant to human disease should be en-
couraged now.
Viral roles in etiology and pathogenesis
I should like to begin by considering the more general problem of how
infectious agents can contribute to the pathogenesis of chronic and degenera-
tive diseases. It seems necessary first to state one perhaps obvious point
relating to the word etiology. While, for any given disease an infectious
agent such as the tubercle bacillus may be the etiologic agent, for many
chronic diseases the relation, if any, of infectious agents may be quite dif-
ferent-preparatory, contributory, or provoking and perhaps relatively
nonspecific. Even when the etiologic agent can be identified, its potential
for disease usually is influenced significantly by other factors. Thus, I would
prefer to speak not of the possible viral etiology of chronic diseases but,
rather, of the possible contribution of viruses to the etiology and patho-
genesis of such diseases.
Almost by definition, the pathogenesis of chronic and degenerative dis-
eases must evolve slowly over a relatively long period. If an infectious agent
(a virus) is to function as the etiologic agent, one can stipulate that it must
do so by one or another of three general mechanisms. First, it may during
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a brief period of infection trigger in the host some irreversible, progressive
process that culminates in the chronic disease. In effect, this appears to be
the case with the known tumor viruses of animals, although the RNA tumor
viruses persist patently in the host indefinitely. Other mechanisms which
do not involve continued presence of the agent or renewed contact are diffi-
cult to conceive. The most evident is some form of autoimmune process.
DNA viruses (including many human adenoviruses) that are oncogenic in
animals, as one consequence of the incorporation of viral material in the
cellular genome, induce the formation of new cellular antigens (T antigens)
to which the host responds immunologically.' Such a mechanism has been
suggested2 as one way in which viruses might contribute to chronic pro-
gressive disease of the central nervous system. Evidence for other mecha-
nisms by which viruses might initiate an autoimmune process has been
reviewed in detail by Isacsont with special emphasis on myxoviruses. Those
myxoviruses (and bacteria) which possess the enzyme neurominidase do
unmask new host antigens (unfortunately, also called T antigens) on sur-
faces of erythrocytes and possibly other host cells and these induce the
formation of specific autoantibodies (T agglutinins). However, the process
is acute and, except for possible but rare hemolytic anemia, has no known
adverse effect on the host. Cytopathic viruses, affecting tissues or organs
normally separated from the host immunologic apparatus, could release
tissue-specific antigens into the circulation which might be regarded as
foreign and lead to immune response. Such a mechanism may underly post-
infectious encephalomyelitis or thyroiditis. However, although leading to
long persisting or permanent sequella, these ordinarily are relatively acute
in evolution and not chronically progressive.
Second, the agent may establish a long persisting relation with the host,
in latent or patent form, at the cellular (or possibly tissue) level. Viruses
(also bedsonia and rickettsiae) afford many known or suspected examples
of such a relation. However, that such persistence results in chronic pro-
gressive disease (progressive vaccinia excluded) is suggested so far in only
a few instances. One is the chronic progressive pneumonia in sheep called
Maedi, the virus of which is antigenically related to visna virus of sheep.'
This virus persists patently in the circulation (and presumably in pulmonary
tissue) despite the concurrent presence of neutralizing antibody.! No close
counterpart agent of man is known. However, if Maedi is a relative of visna
virus, it resembles myxoviruses in morphology and formation by budding
from the host cell membrane.6 Other examples relate to the CNS and include
visna and scrapie in sheep and kuru and subacute sclerosing panencephalitis
in man. The latter is particularly interesting since electron microscopic
studies have revealed intranuclear tubular filaments resembling those seen
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in measles infected cells,7 and measles viral antigen has been visualized in
the brains of three cases by the fluorescent antibody method.8 The mecha-
nisms involved in these cases are still obscure but could include a destruc-
tive immunologic reaction directed against antigens of the persisting viruses.
This would be particularly plausible in the case of lipoprotein coated viruses,
such as measles and other myxoviruses, which may cause viral antigens to
be present in the membranes of chronically infected cells.2 Such immunologic
reaction also could be directed against the affected tissue, initially incited
and continuously stimulated by tissue antigen released in the circulation by
cell lysis or by incorporation in escaping viral particles. Stimulation via
viral particles is somewhat suggested by high measles antibody titers in two
of the above patients and the occurrence of a 16x rise in titer in one. While
response directed against normal tissue antigens seems unlikely in the case
of lower respiratory tissues that are not separated from the immunologic
apparatus, response to viral antigen on the surface of persistently infected
cells is completely plausible.
Of viruses known to infect the human respiratory tract, the adenovirus
group has been shown to establish long persisting infection with periodic
recrudescent shedding in both respiratory and fecal specimens.9 These ob-
servations so far have been made only in young children and do not appear
to be associated with evident disease.10 Some other examples of viral per-
sistence are unassociated with disease (lymphocytic choriomeningitis virus
in congenitally infected mice, serum hepatitis virus in healthy carrier do-
nors), or associated only with acute, nonprogressive disease episodes (fever
blisters due to herpes simplex virus, herpes zoster due to varicella virus,
Brill's disease due to R. prowazeki). The cases of congenital infection in
man with rubella or cytomegaloviruses stand as possible exceptions.
The third general stiuation wherein an infectious agent might act as the
etiologic agent in progressive chronic disease would be when it established
repeated, effective contact over a long period, each time renewing the stimu-
lus to progress of pathogenesis. Because of immunologic specificity which
might result in specific resistance to re-infection, "agent" in this case might
well constitute a group of antigenically distinguishable but biologically simi-
lar agents. In this case pathogenesis could progress either by means of
cumulative tissue destruction and scarring resulting from the acute effects
of successive infections or by a hypersensitivity mechanism dependent on
common antigens shared by members of groups such as adenoviruses, para-
influenza viruses, or even variant strains of influenza virus A and B. That
myxoviruses, at least, can induce hypersensitivity to viral antigen is well
established for mumps (dermal hypersensitivity) and is strongly suggested
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for measles by the occurrence of marked local reactions to live measles virus
vaccine in children previously given killed-virus vaccine.l"'
A partial bacterial model of the immunologic mechanism is the effect of
repeated infections with B-hemolytic streptococci on progression of rheu-
matic heart disease. This example differs from the viral model proposed
in that the streptococcus possesses an antigen having some similarity to
that of heart tissue.1" A possible ex-viral example, adhering more closely
to the model, is that of trachoma where it has been postulated that the
serious permanent conjunctival scarring is the result of hypersensitivity
engendered by repeated re-infections, perhaps including antigenically dis-
tinguishable strains of TRIC agents which share a common hypersensitizing
antigen.1' This model is particularly appealing with respect to CORD for
several reasons. First, it does not necessarily invoke autoimmune response
which, for respiratory tissue, is hard to conceive in view of its lack of
separation from the immunologic apparatus. Second, the conjunctiva and
the respiratory tract mucosal surfaces are superficial sites of infection which
are minimally protected against hom6logous reinfection by the classical
mechanisms of humoral immunity. And third, the predominant class of
antibody in mucous secretions is IgA which does not fix complement. Hence,
it would be ineffective in neutralizing any reinfecting agents in cases in
which complement might be required. This possibility is perhaps less rele-
vant for viruses than for other microbial agents such as mycoplasma that
are known for long persistence.
Reinfections with variant strains of A or B influenza viruses during one
lifetime might well number 10 to 20 per type (based on a 2-3 year cycle
for A and 4 to 5 years for B and allowing some escapes). Reinfections with
RS virus are known to occur"5'1 but how often is unknown. In the case of
parainfluenza viruses, homologous reinfection associated with disease also
occurs17 but again with undocumented frequency. However, there are three
common serotypes (plus two uncommon ones) that have shared antigens,
thus perhaps multiplying by three the number of repeated, related stimuli.
Respiratory reinfection with adenoviruses may not occur but persistent
infection plus successive infections with the 4 or 5 more common serotypes
(antigenically related) could provide repeated viral antigenic stimuli. This
point perhaps has been overly labored but one final comment is required.
Assuming that infection with some or all of these agents does induce hyper-
sensitivity, it may well be that the lifetime number of stimuli by any one
antigen (or group of related antigens) is not enough by itself to cause sig-
nificant disease. However, given hypersensitivity to multiple antigens af-
fecting the same target tissues, their additive separate effects might be
sufficient to cause CORD.
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The proposition that a virus or other infectious agent plays a collabora-
tive role rather than that of the agent is conceptually simple as stated. Its
full development presumably is in the province of those contributors who
are discussing synergistic effects. It is possible, for example, that numerous
episodes of disease of the lower respiratory tract, due to whatever class of
infectious agent, could simply by their collective cumulative tissue damage
determine the progressive development of CORD. Important to such de-
velopment might be the timing (possibly in infancy) and nature (perhaps
severe viral bronchiolitis or pertussis) of the initial episode. Alternatively,
certain bacteria may be the important agents but with preceding or con-
current viral infections as predisposing factors, an acute example being
bacterial pneumonia secondary to influenza or measles. The extent and
character of host response to infection also could be influenced by pre-
existing or concurrent damage of tissues caused by air pollutants including
tobacco smoke or inhaled irritant particulate matter, silicosis and tuber-
culosis providing very specific examples. That at least one noninfectious
environmental factor does contribute importantly is evident from the in-
creased risk of CORD attributable to cigarette smoking.18 Thus, a smoking
machine, may be a necessary adjunct for any investigator seeking to test
an animal model.
Detection of viral contributions
We come now to the problem of how viral contributions to CORD can
be detected in man. This is essentially an epidemiologic problem but one
that must depend heavily on virologic and immunologic methods of obser-
vation. Whatever the role postulated (collaborative or as the etiologic
agent), the problem is complicated by the prolonged pathogenesis and
evolution of CORD and by the large number of viruses that can and, with
varying frequency, do cause lower respiratory tract disease. It is certainly
feasible and important to observe closely patients with clearly evident dis-
ease, as a number of investigators are now doing, in order to detect new
episodes of viral respiratory disease and to determine how each such episode
affects the progress of the disease. Such observations are relevant to any
hypothesis involving repeated stimuli and, to the extent that the episodes
cause measurable progress, they would serve both to support the general
hypothesis and to identify the responsible viruses.
Much more difficult, and correspondingly less certain to be productive
in the light of our present state of knowledge, would be efforts to test those
aspects of the various hypotheses relating to events preceding clinical onset
of CORD, including in particular those related to the initiation of the dis-
ease process. In the long run, it may well be necessary to set up long con-
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tinuing longitudinal studies of sizable populations of the Framingham type
but, perhaps, beginning with a population of very young age as in our Virus
Watch program.9'10'20 Such a study, even if grafted onto some existing
comprehensive medical care program, would constitute a massive under-
taking and its results would be long in evolving.
The more realistic present alternative is to consider what we can do,
given patients with declared CORD for study. Under any given hypothesis,
how would we expect such patients to differ from otherwise similar but
disease-free persons? As a beginning, the possibility was suggested that
viral infection might alter cell antigens. In such event, the affected host
should respond immunologically to such antigen in terms of hypersensitivity
(basis for disease progression) and, possibly, humoral antibody. Patients
whose disease is due to the same virus should possess similarly altered
respiratory tissue antigens to which they are hypersensitive and might well
possess similarly specific autoantibodies. Assuming the latter, attempts
might be made to demonstrate the presence of both antigen and antibody
by use of the indirect fluorescent antibody (FA) method, seeking to stain
biopsy or autopsy tissue specimens treated with autologous serum. Speci-
mens obtained at autopsy, that had been stained with autologous serum,
could be used to explore the presence of antibody in sera from other patients
and from healthy persons. Existence of hypersensitivity might be demon-
strable by dermal tests using extracts of affected tissue as antigen. Quanti-
tative limitations inherent in acceptable biopsy techniques might restrict or
preclude testing patients with autologus antigens but acceptable prepara-
tions could be made from autopsy material.
Hypotheses depending on long persistence of a virus in the host have
in common the expectation that study of CORD patients should provide
evidence of such viral persistence. Studies of this type are, I am sure,
currently underway. Presumably, they include study of biopsy and autopsy
tissue specimens for the presence of viral antigens, using the FA method,
and efforts to recover infectious virus from the same specimens by both
inoculation of extracts into cell cultures or other hosts and attempts to
unmask latent viruses in tissue cultures prepared from the specimen tissues.
While study of serially collected biopsy specimens would be necessary to
prove viral persistence, positive results from single specimens obtained in
the absence of recent acute disease would lend support to the hypothesis
and also again serve to identify candidate responsible viruses. The prob-
lem of satisfactory control specimens poses some obvious difficulties which
I am sure are recognized by the investigators. Parallel serologic studies
would certainly be conducted but might be of limited assistance. Since long
viral persistence should result in either continuous or periodic stimulation
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of antibody production, lack of antibody might exclude the operation of
specific viruses in individual cases. Because of the relative ubiquity of the
most promising candidate viruses, presence of antibody by itself would
have little significance. However, if persistence is associated with continuing
active antigenic stimulation, higher than average titers of antibody might
be expected as reported for measles in two patients with progressive central
nervous system disease.8
The possibility of detecting hypersensitivity to virus-induced new cel-
lular antigens has been discussed already. While hypersensitivity to normal
respiratory tissue antigens has been regarded as improbable (perhaps with
inadequate reason), hypersensitivity to viral antigens was invoked in mecha-
nisms involving either long persistence of virus or repeated effective contact.
In this light, not only should the histopathology of CORD be compatible
with the operation of hypersensitivity (my impression is that it is), but
CORD patients might be expected to react positively to dermal tests with
suitable preparations of viral antigens. Initially, these probably should be
purified suspensions of intact but inactivated viral particles but, assuming
significant positive results, preparations containing different viral fractions
would become important. Except for mumps,' little is known about the
frequency with which viral infections of man induce hypersensitivity to
viral antigens. In addition to recent observations with respect to measles,"'
hypersensitivity to western equine encephalomyelitis virus has been demon-
stratedS and it has long been accepted that the "immune" reaction to
vaccinia in part reflects hypersensitivity since it can be elicited with non-
infective vaccinia virus. Obviously, even less is known about the prevalence
of hypersensitivity to individual viruses. If it is a common sequel to infec-
tion with ubiquitous viruses, it might prove to be nearly as common in
controls as in CORD patients with respect to any given viral antigen. In-
deed, the number of antigens eliciting positive response might be the main
basis of differentiation.
SUMMARY
I should like now to summarize briefly. If viruses play the role of the
etiologic agent in CORD, they may relate to the host briefly, continuously,
or repeatedly. The most reasonable mechanisms for virus-mediated patho-
genesis involve either simple cumulative damage due to repeated episodes
of acute disease (this implies multiple viruses acting nonspecifically) or
some form of hypersensitivity. This latter could be directed either against
a virus-induced new cellular antigen or against a tissue-fixed viral antigen.
Virus also, obviously, could play a collaborative or synergistic role. For
the present, I think studies in man should continue to be focussed on CORD
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patients (and controls). I believe certain types of such studies are feasible
now and may be expected to be productive. The aspects relating to hyper-
sensitivity are especially intriguing to me.
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